MX354137B - Composiciones topicas de minociclina y metodos de uso de la misma. - Google Patents

Composiciones topicas de minociclina y metodos de uso de la misma.

Info

Publication number
MX354137B
MX354137B MX2013008384A MX2013008384A MX354137B MX 354137 B MX354137 B MX 354137B MX 2013008384 A MX2013008384 A MX 2013008384A MX 2013008384 A MX2013008384 A MX 2013008384A MX 354137 B MX354137 B MX 354137B
Authority
MX
Mexico
Prior art keywords
methods
compositions
same
topical minocycline
minocycline compositions
Prior art date
Application number
MX2013008384A
Other languages
English (en)
Other versions
MX2013008384A (es
Inventor
Mansouri Zahra
Original Assignee
Laboratory Skin Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratory Skin Care Inc filed Critical Laboratory Skin Care Inc
Publication of MX2013008384A publication Critical patent/MX2013008384A/es
Publication of MX354137B publication Critical patent/MX354137B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Se proporcionan composiciones tópicas en minociclina con fluorescencia reducida. En algunos casos, las composiciones incluyen una cantidad de un agente activo de minociclina asociada con partículas porosas de calcio. También se proporciona métodos para utilizar las composiciones, p. eje., en el tratamiento del acné.
MX2013008384A 2011-01-19 2012-01-19 Composiciones topicas de minociclina y metodos de uso de la misma. MX354137B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161434368P 2011-01-19 2011-01-19
PCT/US2012/021926 WO2012100097A2 (en) 2011-01-19 2012-01-19 Topical minocycline compositions and methods of using the same

Publications (2)

Publication Number Publication Date
MX2013008384A MX2013008384A (es) 2014-07-30
MX354137B true MX354137B (es) 2018-02-14

Family

ID=46516388

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008384A MX354137B (es) 2011-01-19 2012-01-19 Composiciones topicas de minociclina y metodos de uso de la misma.

Country Status (13)

Country Link
US (3) US9539266B2 (es)
EP (1) EP2665483B1 (es)
JP (1) JP2014502999A (es)
KR (1) KR102044236B1 (es)
CN (2) CN108619519A (es)
AU (1) AU2012207203B2 (es)
BR (1) BR112013018352A2 (es)
CA (1) CA2861357C (es)
EA (1) EA031630B1 (es)
IL (1) IL227538B (es)
MX (1) MX354137B (es)
SG (2) SG192028A1 (es)
WO (1) WO2012100097A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
WO2015066717A1 (en) 2013-11-04 2015-05-07 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
IN2013MU03646A (es) * 2013-11-20 2015-07-31 Lupin Ltd
EP3261619A4 (en) 2015-02-25 2018-10-24 Sun Pharma Advanced Research Company Ltd Nanoparticulate composition
JP6793715B2 (ja) 2015-03-23 2020-12-02 バイオファーミクス・インコーポレイテッドＢｉｏＰｈａｒｍＸ， Ｉｎｃ． テトラサイクリンの皮膚用医薬組成物
US20160287615A1 (en) * 2015-04-03 2016-10-06 BioPharmX, Inc. Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical application
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
WO2021191273A1 (en) 2020-03-24 2021-09-30 Hovione Scientia Limited Compositions for use in treating meibomian gland dysfunction

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases
DE3613213A1 (de) * 1986-04-18 1987-10-22 Merck Patent Gmbh Tricalciumphosphat fuer implantationsmaterialien
US4948575A (en) 1989-01-24 1990-08-14 Minnesota Mining And Manufacturing Company Alginate hydrogel foam wound dressing
JPH0832551B2 (ja) 1989-06-24 1996-03-29 旭光学工業株式会社 多孔質リン酸カルシウム系化合物粒子及びその製造方法
US5292495A (en) 1991-05-27 1994-03-08 Kowa-Chemical Industry Co., Ltd. Porous particles of calcium carbonate and method for the preparation thereof
US5604200A (en) 1994-05-02 1997-02-18 Taylor-Mccord; Darlene Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing
US5674539A (en) 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US6096324A (en) 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US5607980A (en) * 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US6395311B2 (en) 1998-04-29 2002-05-28 Univera Pharmaceuticals, Inc. Multicomponent biological vehicle
US6573249B2 (en) 2000-02-15 2003-06-03 Alphamed Pharmaceutical Corp. Topical wound therapeutic compositions
US6262020B1 (en) 2000-02-15 2001-07-17 Alphamed Pharmaceuticals Corp. Topical wound therapeutic compositions
CN1106861C (zh) 2000-05-19 2003-04-30 清华大学 纳米相钙磷盐/胶原/聚乳酸骨复合多孔材料的制备方法
JP4161031B2 (ja) 2000-10-31 2008-10-08 独立行政法人産業技術総合研究所 亜鉛含有リン酸カルシウム微粒子含有懸濁液または粒子溶媒混合系及び亜鉛欠乏症治療剤
US20030018587A1 (en) 2001-07-20 2003-01-23 Althoff Oliver T. Checkout system for on-line, card present equivalent interchanges
US7005136B2 (en) * 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
JP2004075662A (ja) 2002-06-20 2004-03-11 Mukku:Kk 徐放性組成物、その製造方法およびその製剤
WO2004076352A1 (ja) 2003-02-27 2004-09-10 Okutama Kogyo Co., Ltd. 球状炭酸カルシウム及びその製造方法
US20040180091A1 (en) 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
WO2004091577A1 (en) 2003-04-17 2004-10-28 Porten Pharmaceutical Ab Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions
DE10323175A1 (de) 2003-05-22 2004-12-23 TÜV Industrie Service GmbH - TÜV Rheinland Group Prüfhebel
US7348060B2 (en) 2003-08-22 2008-03-25 National Insititute For Materials Science Porous and spherical calcium phosphate particle comprising metal ion, and porous multilayer calcium phophate particle
BRPI0507680A (pt) 2004-02-13 2007-07-17 Nod Pharmaceuticals Inc partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
SE527610C2 (sv) 2004-06-15 2006-04-25 Promimic Ab Förfarande för framställning av syntetiskt, kristallint kalciumfosfat i nanostorlek
US20060025735A1 (en) 2004-07-30 2006-02-02 Berg Charles J Jr Absorbent article with color matched surfaces
RU2357758C2 (ru) 2004-10-07 2009-06-10 Кабусики Кайся Санги Препараты для чрескожной и чресслизистой доставки
WO2006050368A2 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
US20060257358A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
US8147860B2 (en) * 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
JP4766606B2 (ja) 2006-03-30 2011-09-07 パウダーテック株式会社 電子写真現像剤用フェライトキャリア及びその製造方法、並びに電子写真現像剤
US20080051335A1 (en) 2006-05-02 2008-02-28 Kleiner Lothar W Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
US20080063681A1 (en) * 2006-09-11 2008-03-13 Ebi, L.P. Therapeutic bone replacement material
US20100136117A1 (en) 2006-10-05 2010-06-03 De Groot Klaas Hydroxyapatite tissue filler and its preparation and use
EP2462895B1 (en) 2006-11-03 2016-11-02 BioMimetic Therapeutics, LLC Compositions and methods for arthrodetic procedures
JP2008291010A (ja) 2007-04-26 2008-12-04 Galenisearch Laboratories Inc 局所滞留性徐放性マイクロ粒子
US20090214601A1 (en) * 2007-09-28 2009-08-27 Chappa Ralph A Porous Drug Delivery Devices and Related Methods
MY162982A (en) * 2008-09-23 2017-07-31 Laboratory Skin Care Inc Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
TWI556839B (zh) * 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
WO2011016772A1 (en) 2009-08-04 2011-02-10 Biomatcell Ab Ion substituted calcium phosphate particles

Also Published As

Publication number Publication date
US20170189427A1 (en) 2017-07-06
US20190134067A1 (en) 2019-05-09
KR102044236B1 (ko) 2019-11-13
WO2012100097A3 (en) 2012-10-26
BR112013018352A2 (pt) 2019-08-27
AU2012207203A1 (en) 2013-08-22
CN108619519A (zh) 2018-10-09
EA201391030A1 (ru) 2014-07-30
KR20140083921A (ko) 2014-07-04
EP2665483A2 (en) 2013-11-27
US20140186442A1 (en) 2014-07-03
AU2012207203B2 (en) 2017-08-03
IL227538A0 (en) 2013-09-30
SG192028A1 (en) 2013-08-30
EA031630B1 (ru) 2019-01-31
IL227538B (en) 2018-07-31
EP2665483B1 (en) 2020-08-26
US9539266B2 (en) 2017-01-10
MX2013008384A (es) 2014-07-30
US10080764B2 (en) 2018-09-25
US10653707B2 (en) 2020-05-19
SG10201600332TA (en) 2016-02-26
WO2012100097A2 (en) 2012-07-26
EP2665483A4 (en) 2015-11-11
JP2014502999A (ja) 2014-02-06
CA2861357A1 (en) 2012-07-26
CA2861357C (en) 2022-08-23
CN103781485A (zh) 2014-05-07

Similar Documents

Publication Publication Date Title
MX354137B (es) Composiciones topicas de minociclina y metodos de uso de la misma.
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
WO2015002724A3 (en) SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
MX352985B (es) Formulaciones desinfectantes topicas y uso de las mismas.
WO2012106281A3 (en) Multimodal trail molecules and uses in cellular therapies
GB201106750D0 (en) Novel compounds
MX2019008211A (es) Estructuras fibrosas que comprenden particulas y metodos para fabricarlas.
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
GB201316021D0 (en) Vitamin D composition
MX340323B (es) Composiciones formadoras de gel in situ.
MX2013002058A (es) Composicion de tratamiento para cabello.
MY161601A (en) Films and compositions comprising the same
IN2014DN06104A (es)
MX2014004459A (es) Inhibidores de peptidos de la proteina precursora amiloide de sitio b que escinde la enzima 1 (bace1).
MX349681B (es) Composisiones para el cuidado oral.
MX357284B (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
AU336402S (en) Spreading applicator
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
PL2753182T3 (pl) Środki czynne przeciw szczepom Pseudomonas powodującym choroby gnilne w uprawach grzybów, ich zastosowanie i zawierające je kompozycje
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
MX356102B (es) Compuestos y métodos para tratar leucemia.
MX348147B (es) Biarilsulfonamidas utiles en el tratamiento de la inflamacion y cancer.
WO2014031982A3 (en) Methods and compositions for treating pain
AU2012240388A8 (en) Treatment regimens
WO2013076729A8 (en) Otomeria plants

Legal Events

Date Code Title Description
FG Grant or registration